Research article
What is the quality of drug therapy clinical practice guidelines in Canada?
Ian D. Graham, Susan Beardall, Anne O. Carter, Judith Glennie, Paul C. Hébert, Jacqueline M. Tetroe, Finlay A. McAlister, Silvia Visentin and Geoffrey M. Anderson
CMAJ July 24, 2001 165 (2) 157-163;
Ian D. Graham
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Susan Beardall
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Anne O. Carter
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Judith Glennie
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Paul C. Hébert
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Jacqueline M. Tetroe
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Finlay A. McAlister
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Silvia Visentin
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
Geoffrey M. Anderson
From *the Departments of Medicine and of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont.; †the Canadian Population Health Initiative, Canadian Institute for Health Information, Ottawa, Ont.; ‡the Department of Community Medicine, United Arab Emirates University, Al Ain, United Arab Emirates; §the Therapeutic Products Directorate, Health Canada, Ottawa, Ont.; ¶the Faculty of Medicine, University of Ottawa, Ottawa, Ont.; **the Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Alta.; ††the Clinical Epidemiology Unit, Ottawa Hospital — Civic Campus, Ottawa, Ont.; and ‡‡the Faculty of Health Administration, University of Toronto, Toronto, Ont.
In this issue
Article tools
Respond to this article
What is the quality of drug therapy clinical practice guidelines in Canada?
Ian D. Graham, Susan Beardall, Anne O. Carter, Judith Glennie, Paul C. Hébert, Jacqueline M. Tetroe, Finlay A. McAlister, Silvia Visentin, Geoffrey M. Anderson
CMAJ Jul 2001, 165 (2) 157-163;
Jump to section
Related Articles
Cited By...
- Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma
- Making Evidence Available for Hospital-Based Midwives: A Systematic Examination of the Content and Methodological Quality of Three Protocols Used in Maternity Hospitals in the Netherlands
- Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation
- Knowledge creation: synthesis, tools and products
- Evidence and advocacy: Are all things considered?
- Conflict between Guideline Methodologic Quality and Recommendation Validity: A Potential Problem for Practitioners
- Ottawa Panel Evidence-Based Clinical Practice Guidelines for Therapeutic Exercises and Manual Therapy in the Management of Osteoarthritis
- Evaluation and adaptation of clinical practice guidelines
- Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N)
- International Assessment of the Quality of Clinical Practice Guidelines in Oncology Using the Appraisal of Guidelines and Research and Evaluation Instrument
- Assessing the quality of clinical practice guidelines
- Assessing the quality of clinical practice guidelines
- Assessing the quality of clinical practice guidelines
- Further disquiet on the guidelines front
- Le moment est venu de desherber le jardin des guides de pratique:
- Time to weed the CPG garden